Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
© 2014, Yamwong et al.; licensee Springer. Objectives: To evaluate the long-term cost-effectiveness of ticagrelor and ASA versus generic and branded clopidogrel and ASA in patients with ACS based on a Thai cost database. Methods: A one-year decision tree and a long-term Markov model were constructed...
Saved in:
Main Authors: | Sukit Yamwong, Unchalee Permsuwan, Sirana Tinmanee, Piyamitr Sritara |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84971330865&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44938 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
by: Sukit Yamwong, et al.
Published: (2018) -
Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
by: Sukit Yamwong, et al.
Published: (2018) -
Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
by: Zhao, YJ, et al.
Published: (2021) -
Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: A Singapore healthcare perspective
by: Chin, C.T., et al.
Published: (2014) -
Ticagrelor monotherapy in aspirin-allergic patients post-coronary stenting after acute coronary syndrome: A case series
by: Chang GSW, et al.
Published: (2020)